Trials / Not Yet Recruiting
Not Yet RecruitingNCT03884569
Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD)
Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD): an Observational Study on Safety and Effectiveness
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
CLET is a published treatment for the management of corneal failure due to extensive LSCD. Due to our previous studies on this novel treatment, the regulatory agency of Spain "Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)" authorized our institution (IOBA-University of Valladolid) to perform this kind of therapy (CLET) in a case-by-case base following the Special Situation Medicines Policy Procedure in Spain. Upon approval of the permanent authorization patients will be included as specified by AEMPS.The objective of this study is to perform a protocolized treatment and follow up so that results can be reported to the scientific community.
Conditions
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2019-03-21
- Last updated
- 2025-05-16
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03884569. Inclusion in this directory is not an endorsement.